Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis
- 1 December 1994
- journal article
- case report
- Published by Wolters Kluwer Health in Hepatology
- Vol. 20 (6) , 1437-1441
- https://doi.org/10.1002/hep.1840200610
Abstract
We describe a 33-yr-old pregnant woman in whom a primary biliary cirrhosis—like syndrome developed after 2 wk of chlorpromazine therapy. The clinical course was characterized by severe jaundice lasting 22 mo, intense pruritus, fever, steatorrhea, high alkaline phosphatase levels and hypercholesterolemia. Jaundice resolved with initiation of ursodeoxycholic acid therapy, but subclinical cholestasis and low-level inflammatory activity persisted and ultimately evolved into biliary cirrhosis. The pathological substrate of this severe and prolonged cholestatic reaction was found to be the vanishing bile duct syndrome with a marked transient pseudoxanthomatosis. (Hepatology 1994;20:1437-1441).Keywords
This publication has 18 references indexed in Scilit:
- Active chronic hepatitis after chlorpromazine ingestion.BMJ, 1973
- Chronic Chlorpromazine Cholangiolitic HepatitisGastroenterology, 1966
- Chlorpromazine: Ten Years' ExperiencePublished by American Medical Association (AMA) ,1963
- Xanthomatous biliary cirrhosis following chlorpromazineThe American Journal of Medicine, 1961
- Chronic chlorpromazine jaundiceThe American Journal of Medicine, 1961
- PROLONGED PHENOTHIAZINE HEPATITIS : REPORT OF A CASEAmerican Journal of Psychiatry, 1960
- CLINICAL ASPECTS OF JAUNDICE RESULTING FROM INTRAHEPATIC OBSTRUCTIONJAMA, 1959
- Chlorpromazine JaundiceA.M.A. Archives of Internal Medicine, 1958
- THERAPEUTIC AND TOXIC EFFECTS OF CHLORPROMAZINE AMONG 3,014 HOSPITALIZED CASESAmerican Journal of Psychiatry, 1957
- COMPLICATIONS OF CHLORPROMAZINE THERAPY IN 800 MENTAL-HOSPITAL PATIENTSThe Lancet, 1955